News

Genentech said that the application is based on positive results from a Phase III study, known as ToGA, which showed that people who received Herceptin plus chemotherapy lived

Advanced Cell Technology said that the studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues. The studies were designed to address

A product development team (PDT) comprised of representatives from Pfizer, MMV and the London School of Hygiene and Tropical Medicine (LSHTM) are expected to coordinate the trials and

Sunitinib is currently approved for both gastrointestinal stromal tumors (GIST) after disease progression on or intolerance to imatinib mesylate, and advanced / metastatic renal cell carcinoma (RCC) based

Seroquel XR is an antipsychotic medicine that contains quetiapine, used in patients with schizophrenia. Quetiapine attaches to several receptors on the surface of nerve cells and helps to

The milestone was triggered by Micromet’s achievement of pre-clinical for a BiTE antibody for the treatment of solid tumors. BiTE antibodies are designed to direct the body’s cytotoxic,

Simultaneously, Actelion Pharmaceuticals has launched Prospect registry, a multicenter, observational, US-based registry that will provide additional clinical experience on patients being treated with Epoprostenol for Injection. Epoprostenol for

The acquisition is expected to give Piramal access to key intellectual property developed by BSV for the manufacture of injectible anesthetic products including process based intellectual property and

The issued patent covers Mystic’s unit dose blister technology for packaging of drugs or biologics that have been freeze dried to powder form to improve stability, reduce the